Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Avinger, Inc. - Common Stock (NQ:AVGR)

0.4740 UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avinger, Inc. - Common Stock

< Previous 1 2 3 Next >
Avinger Expands Lightbox 3 First Case Experience
Patients Treated in Four Additional Hospitals Using New Portable System REDWOOD CITY, CA / ACCESSWIRE / March 7, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing... 
From Avinger, Inc.
Via AccessWire
Avinger Announces Successful Completion of First Cases with the Lightbox 3 Next Generation Imaging Console
REDWOOD CITY, CA / ACCESSWIRE / February 28, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system... 
From Avinger, Inc.
Via AccessWire
Avinger Announces Closing of $7.6 Million Registered Direct Offering
REDWOOD CITY, CA / ACCESSWIRE / January 14, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company marketing the first and only intravascular image-guided,... 
From Avinger, Inc.
Via AccessWire
Avinger Announces $7.6 Million Registered Direct Offering
REDWOOD CITY, CA / ACCESSWIRE / January 12, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company marketing the first and only intravascular image-guided,... 
From Avinger, Inc.
Via AccessWire
Avinger Announces 510(k) Clearance for Lightbox 3 Next-Generation Imaging Console
REDWOOD CITY, CA / ACCESSWIRE / January 11, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system... 
From Avinger, Inc.
Via AccessWire
Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis
New indication expands addressable market for Pantheris REDWOOD CITY, CA / ACCESSWIRE / November 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first... 
From Avinger, Inc.
Via AccessWire
Avinger Reports Third Quarter 2021 Financial Results
REDWOOD CITY, CA / ACCESSWIRE / November 11, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system... 
From Avinger, Inc.
Via AccessWire
Avinger to Announce Third Quarter Results on November 11, 2021
REDWOOD CITY, CA / ACCESSWIRE / October 29, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system... 
From Avinger, Inc.
Via AccessWire
Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA
Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent Restenosis REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage... 
From Avinger, Inc.
Via AccessWire
Avinger To Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15
REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system... 
From Avinger, Inc.
Via AccessWire
Avinger OCT-Guided Technologies Featured at AMP 2021
REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system... 
From Avinger, Inc.
Via AccessWire
Avinger Reports Second Quarter 2021 Financial Results
Pantheris Sales and Tigereye™ Expansion Drive 91% Year-Over-Year Revenue Growth REDWOOD CITY, CA / ACCESSWIRE / August 10, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company... 
From Avinger, Inc.
Via AccessWire
Avinger Announces 510(k) Filing for New Lightbox 3 Imaging Console
Smaller Footprint, Improved User Experience and Lower Cost to Drive Adoption REDWOOD CITY, CA / ACCESSWIRE / August 9, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company... 
From Avinger, Inc.
Via AccessWire
Avinger to Announce Second Quarter 2021 Results on August 10, 2021
REDWOOD CITY, CA / ACCESSWIRE / July 27, 2021 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis Indication
REDWOOD CITY, CA / ACCESSWIRE / July 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger Announces Key Opinion Leader Presentations at Vascular Conferences in Germany
REDWOOD CITY, CA / ACCESSWIRE / June 28, 2021 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
REDWOOD CITY, CA / ACCESSWIRE / June 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger Announces Issuance and Allowance of Seven U.S. Patents
REDWOOD CITY, CA / ACCESSWIRE / May 25, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Topics Intellectual Property
Avinger To Present at the Oppenheimer MedTech, Tools & Diagnostics Summit May 26
REDWOOD CITY, CA / ACCESSWIRE / May 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger Reports First Quarter 2021 Financial Results
13% Year-over-Year Revenue Growth Driven by Tigereye™ Commercial Launch and Pantheris SV Sales Growth REDWOOD CITY, CA / ACCESSWIRE / May 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage... 
From Avinger, Inc.
Via AccessWire
Avinger to Announce First Quarter 2021 Results on May 6, 2021
REDWOOD CITY, CA / ACCESSWIRE / April 26, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
New Publications Highlight Clinical Benefits of Avinger PAD Therapies
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system... 
From Avinger, Inc.
Via AccessWire
Avinger Achieves Commercial Milestone with More Than 100 Accounts Using Pantheris SV
REDWOOD CITY, CA / ACCESSWIRE / April 15, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system... 
From Avinger, Inc.
Via AccessWire
Clinical Trials Critical for the Evaluation of Advanced Medical Imaging Tools
Via FinancialNewsMedia
Avinger Provides Update on Tigereye(TM) Commercial Launch
REDWOOD CITY, CA / ACCESSWIRE / April 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.